Malaria is a mosquito-borne infectious disease which is widespread in tropical and subtropical regions such as Sub-Saharan Africa, Asia and the Americas. A recent study has determined that one third of malaria medicine in these regions is either poor-quality or fake. Researchers looked at 1,500 samples of seven malaria drugs from seven countries in South East Asia according to BBC and determined that both counterfeit and mediocre substitutes of the tablets were prevalent. The same proved true when data was obtained from 21 countries in sub-Saharan Africa when analyzing 2,500 drug samples. This in turn causes both drug resistance and treatment failure for those afflicted with malaria.
This has been one of the first large scale studies to test drug quality in India or China and researchers believe the problem is actually much bigger than these tests show. Many cases go unreported and unnoticed with little action taken again counterfeiters.
The researchers believe that in order to stop the problem, facilities must be put in place to monitor the quality of these antimalarial drugs. This is necessary to maintain a standard of effective treatments that will help rid the world of this disease.